Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 5Other hematologic neoplasm 2Lymphoid 2Breast 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myeloid, Acute 2

Interventions

Cyclophosphamide 166Rituximab 155Specimen Handling 114Biopsy 91Magnetic Resonance Spectroscopy 90Vincristine 85Doxorubicin 79Prednisone 78fludarabine 69venetoclax 67obinutuzumab 62ibrutinib 54Lenalidomide 53Dexamethasone 53Cytarabine 47Methotrexate 44acalabrutinib 42Etoposide 41CT-P10 40blinatumomab 38fludarabine phosphate 34Bendamustine Hydrochloride 34prednylidene 32Gemcitabine 32deltacortene 31Calcium Dobesilate 30zanubrutinib 29pembrolizumab 29glofitamab 28Nivolumab 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Control Groups × Lymphoid × 90 days × Clear all
NCT07562568 2026-05-01

SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS

The First Affiliated Hospital of Soochow University

Phase 2 Not yet recruiting
160 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06816134 2026-04-23

Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia

The First Affiliated Hospital of Soochow University

Phase 2 Recruiting
48 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡